BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 9326724)

  • 1. Antagonism of interleukin-1 (IL-1)-induced uveitis with synthetic IL-1 blockers.
    Chiou GC; Chen Z; Xuan B; Yamasaki T; Okawara T
    J Ocul Pharmacol Ther; 1997 Oct; 13(5):427-33. PubMed ID: 9326724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective treatment of experimental uveitis with interleukin-1 blockers, CK 123 and CK 124.
    Xuan B; Chiou GC; Chen Z; Yamasaki T; Okawara T
    J Ocul Pharmacol Ther; 1998 Feb; 14(1):31-44. PubMed ID: 9493781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of ocular inflammation induced by lens protein, endotoxin, and interleukin-1 with synthetic interleukin-1 blockers.
    Chiou GC; Yao QS; Okawara T
    J Ocul Pharmacol; 1994; 10(3):577-86. PubMed ID: 7836867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-inflammation and antifibroblastic actions of interleukin-1 blockers.
    Chiou GC; Xuan B; Yamasaki T; Okawara T
    J Ocul Pharmacol Ther; 1998 Aug; 14(4):375-88. PubMed ID: 9715441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of antagonism of interleukin-1 alpha by synthetic interleukin-1 blockers.
    Xiao JG; Schwade N; Chiou GC
    J Ocul Pharmacol Ther; 1995; 11(3):369-78. PubMed ID: 8590269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of synthetic interleukin-1 blockers on uveitis in rats].
    Zhou Y; Li Z; An W; Chiou G
    Zhonghua Yan Ke Za Zhi; 2000 Jan; 36(1):62-4. PubMed ID: 11853587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of interleukin-1alpha-induced uveitis and inhibition of fibroblast-like cell proliferation by synthetic interleukin-1 blockers.
    Chiou GC; Zhou YH; Xuan B; Yamasaki T; Okawara T
    J Ocul Pharmacol Ther; 1999 Aug; 15(4):351-62. PubMed ID: 10463874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiuveitis and inhibition of fibroblast-like corneal and conjunctival cell cultures by interleukin-1 blockers, CK 125, CK 126 and CK 128.
    Xuan B; Chiou GC; Yamasaki T; Okawara T
    Ophthalmic Res; 1998; 30(3):180-8. PubMed ID: 9618722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effects of interleukin-1 blockers on corneal fibroblast proliferation.
    Chen Z; Liu SX; Chiou GC
    J Ocul Pharmacol Ther; 1996; 12(2):169-82. PubMed ID: 8773933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of interleukin-1 blockers on ophthalmic wound healing in a rabbit model of trabeculectomy.
    Schwade ND; Chiou GC
    J Ocul Pharmacol Ther; 1995; 11(2):125-34. PubMed ID: 8564633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention and treatment of ocular inflammation with a new class of non-steroidal anti-inflammatory agents.
    Chiou GC; Yao QS; Chang MS; Okawara T
    J Ocul Pharmacol; 1994; 10(1):335-47. PubMed ID: 8207338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic anti-inflammation by synthetic interleukin-1 blockers.
    Chiou GC; Liu SX
    Zhongguo Yao Li Xue Bao; 1999 May; 20(5):405-8. PubMed ID: 10678085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of interleukin-1-induced uveitis and corneal fibroblast proliferation by interleukin-1 blockers.
    Chiou GC; Xuan B; Liu Q; Yamasaki T; Okawara T
    J Ocul Pharmacol Ther; 2000 Oct; 16(5):407-18. PubMed ID: 11110032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of trabeculectomy to study the pharmacological modulation of ophthalmic wound healing.
    Schwade ND; Chiou GC
    J Ocul Pharmacol Ther; 1995; 11(2):113-23. PubMed ID: 8564632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms of topical anti-inflammatory effects of lipoxin A(4) in endotoxin-induced uveitis.
    Medeiros R; Rodrigues GB; Figueiredo CP; Rodrigues EB; Grumman A; Menezes-de-Lima O; Passos GF; Calixto JB
    Mol Pharmacol; 2008 Jul; 74(1):154-61. PubMed ID: 18413658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of fibroblast-like cell proliferation by interleukin-1 blockers, CK-119 and CK-122.
    Bo X; Chiou GC
    Zhongguo Yao Li Xue Bao; 1998 Jul; 19(4):304-8. PubMed ID: 10375772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tetrandrine inhibits breakdown of blood-aqueous barrier induced by endotoxin and interleukin-1 alpha in rats.
    Xiao JG; Chiou GC
    J Ocul Pharmacol Ther; 1996; 12(3):323-9. PubMed ID: 8875338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of interleukin-1 blockers, CK112, and CK116 on rat experimental choroidal neovascularization in vivo and endothelial cell cultures in vitro.
    Zou Y; Xu X; Chiou GC
    J Ocul Pharmacol Ther; 2006 Feb; 22(1):19-25. PubMed ID: 16503771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of TNF alpha, IL-1 beta and IL-1 receptor antagonist in LPS-induced rabbit uveitis.
    Mo JS; Matsukawa A; Ohkawara S; Yoshinaga M
    Exp Eye Res; 1998 May; 66(5):547-57. PubMed ID: 9628802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical administration of diminazene aceturate decreases inflammation in endotoxin-induced uveitis.
    Zheng C; Lei C; Chen Z; Zheng S; Yang H; Qiu Y; Lei B
    Mol Vis; 2015; 21():403-11. PubMed ID: 25883526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.